Doximity Overview
Doximity Target Price
Analysts' 12-month price predictions for DOCS.
Share Price
$61.69
Average Target Price
$55.67
9.8% downside
9.8% downside3 analysts in the last 4 months
High: $65 | Low: $50
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-05-20 | Goldman SachsDavid Roman | $50 | 18.9% downside |  |
| 2025-05-16 | Truist FinancialJailendra Singh | $52 | 15.7% downside | |
| 2025-05-16 | Raymond JamesBrian Peterson | $65 |  5.4% upside | |
| 2025-01-13 | Wells FargoStan Berenshteyn | $43 | 30.3% downside | |
| 2025-01-08 | KeyBancScott Schoenhaus | $65 | 5.4% upside | |
| 2024-11-14 | Truist FinancialJailendra Singh | $49 | 20.6% downside | |
| 2024-11-13 | Canaccord GenuityRichard Close | $60 | 2.7% downside | |
| 2024-11-08 | NeedhamScott Berg | $65 | 5.4% upside | |
| 2024-11-08 | Wells FargoStan Berenshteyn | $41 | 33.5% downside | |
| 2024-11-08 | KeyBancScott Schoenhaus | $70 | 13.5% upside | |
| 2024-10-15 | BarclaysStephanie Davis | $52 | 15.7% downside | |
| 2024-10-08 | Evercore ISIElizabeth Anderson | $45 | 27.1% downside | |
| 2024-10-07 | Bank of America SecuritiesAllen Lutz | $45 | 27.1% downside | |
| 2024-08-09 | NeedhamScott Berg | $38 | 38.4% downside | |
| 2024-05-17 | BarclaysStephanie Davis | $31 | 49.7% downside | |
| 2024-05-17 | Truist FinancialJailendra Singh | $31 | 49.7% downside | |
| 2024-05-17 | Evercore ISIElizabeth Anderson | $29 | 53% downside | |
| 2024-04-23 | Morgan StanleyCraig Hettenbach | $25 | 59.5% downside | |
| 2024-04-01 | Evercore ISIElizabeth Anderson | $30 | 51.4% downside | |
| 2022-10-23 | Evercore ISIElizabeth Anderson | $28 | 54.6% downside | |
| 2022-08-05 | Piper SandlerJessica Tassan | $39 | 36.8% downside | |